Profile data is unavailable for this security.
About the company
Kinarus Therapeutics Holding AG is a Switzerland-based Company that operates as a biopharmaceutical industry engaged in diseases treatment. The Company conducts its work within clinical-stage area and its activities include discovery, examination and development of medicines that are intended for the treatment of viral, respiratory, and ophthalmic diseases. Kinraus therapeutic drug is patent protected KIN001 which is a combination of pamapimod and pioglitazone. KIN0001 offers oral, long-term treatment of diseases with severe impact on the comfort of living.
- Revenue in CHF (TTM)0.00
- Net income in CHF-49.38m
- Incorporated1997
- Employees15.00
- LocationKinarus Therapeutics Holding AGTechnologiepark BaselHochbergerstrasse 60CBASEL 4057SwitzerlandCHE
- Phone+41 616332971
- Fax+41 445000801
- Websitehttp://www.kinarus.com/
More ▼